Stockreport

Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense' [Yahoo! Finance]

Tourmaline Bio, Inc.  (TRML) 
PDF Tourmaline Bio shares skyrocketed Tuesday after Novartis agreed to buy the cardiovascular-focused biotech company for $1.4 billion. Continue Reading [Read more]